Biotricity Inc (NASDAQ:BTCY) — Market Cap & Net Worth
Market Cap & Net Worth: Biotricity Inc (BTCY)
Biotricity Inc (NASDAQ:BTCY) has a market capitalization of $2.87 Million ($2.87 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29640 globally and #6038 in its home market, demonstrating a 4.05% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Biotricity Inc's stock price $0.11 by its total outstanding shares 26567769 (26.57 Million). Also see Biotricity Inc balance sheet assets for a full breakdown of the balance sheet.
Biotricity Inc Market Cap History: 2016 to 2026
Biotricity Inc's market capitalization history from 2016 to 2026. Data shows change from $411.27 Million to $2.87 Million (-37.62% CAGR). Also see Biotricity Inc cash conversion from operations for how efficiently the company converts equity into cash flow.
Biotricity Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Biotricity Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check BTCY stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.56x
Biotricity Inc's market cap is 0.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $100.44 Million | $398.20K | -$8.59 Million | 252.24x | N/A |
| 2020 | $117.68 Million | $1.42 Million | -$11.07 Million | 83.01x | N/A |
| 2021 | $634.44 Million | $3.38 Million | -$15.49 Million | 187.44x | N/A |
| 2022 | $71.41 Million | $7.65 Million | -$29.13 Million | 9.33x | N/A |
| 2023 | $30.55 Million | $9.64 Million | -$18.66 Million | 3.17x | N/A |
| 2024 | $7.44 Million | $12.06 Million | -$14.09 Million | 0.62x | N/A |
| 2025 | $7.68 Million | $13.79 Million | -$8.42 Million | 0.56x | N/A |
Competitor Companies of BTCY by Market Capitalization
Companies near Biotricity Inc in the global market cap rankings as of September 18, 2026. Review BTCY tangible net assets ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Biotricity Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #125 globally with a market cap of $177.99 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #229 globally with a market cap of $109.23 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #125 | Abbott Laboratories | NYSE:ABT | $177.99 Billion | $102.36 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.60 |
| #229 | Stryker Corporation | NYSE:SYK | $109.23 Billion | $284.76 |
| #239 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Biotricity Inc Historical Marketcap From 2016 to 2026
Between 2016 and today, Biotricity Inc's market cap moved from $411.27 Million to $ 2.87 Million, with a yearly change of -37.62%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.87 Million | -62.62% |
| 2025 | $7.68 Million | +3.18% |
| 2024 | $7.44 Million | -75.65% |
| 2023 | $30.55 Million | -57.22% |
| 2022 | $71.41 Million | -88.74% |
| 2021 | $634.44 Million | +439.11% |
| 2020 | $117.68 Million | +17.16% |
| 2019 | $100.44 Million | +31.27% |
| 2018 | $76.52 Million | -93.68% |
| 2017 | $1.21 Billion | +194.22% |
| 2016 | $411.27 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Biotricity Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.87 Million USD |
| MoneyControl | $2.87 Million USD |
| MarketWatch | $2.87 Million USD |
| marketcap.company | $2.87 Million USD |
| Reuters | $2.87 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Biotricity Inc
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux and Biocore Pro, an integrated ECG device and software that utilizes … Read more